F/M Investments’s Transmedics TMDX Stock Holding History

F/M Investments’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.45M	Buy	51,906 +11,820	+29%	+$1M	0.18%	94
2026 Q1	$3.98M	Sell	40,086 -25,453	-39%	-$3.32M	0.26%	76
2025 Q4	$7.97M	Buy	65,539 +8,627	+15%	+$1.08M	0.3%	78
2025 Q3	$6.39M	Buy	56,912 +3,584	+7%	+$420K	0.25%	93
2025 Q2	$7.15M	Buy	53,328 +1,461	+3%	+$160K	0.26%	78
2025 Q1	$3.49M	Buy	51,867 +979	+2%	+$67.3K	0.14%	160
2024 Q4	$3.17M	Sell	50,888 -21,574	-30%	-$2.01M	0.12%	164
2024 Q3	$11.4M	Sell	72,462 -283	-0.4%	-$43.6K	0.36%	87
2024 Q2	$11M	Buy	+72,745	New	+$8.73M	0.4%	77

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

F/M Investments's TMDX Position: Q2 2026 in Review

F/M Investments increased its Transmedics (TMDX) stake by 29% in Q2 2026, buying an estimated $1M and bringing the position to 51,906 shares worth $3.45M. The position accounts for 0.18% of the portfolio, ranked #94.

F/M Investments first reported a position in TMDX in Q2 2024 and has held it in 9 quarters since. The position peaked at $11.4M in Q3 2024. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

F/M Investments held 51,906 shares of Transmedics worth $3.45M as of Q2 2026.
F/M Investments bought 11,820 Transmedics shares in Q2 2026, an estimated $1M.
Transmedics made up 0.18% of F/M Investments's portfolio in Q2 2026, its #94 holding.
F/M Investments first reported a position in Transmedics in Q2 2024 and has held it in 9 quarters since.
F/M Investments's Transmedics position peaked at $11.4M in Q3 2024.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.